← Back to Clinical Trials
Recruiting NCT06727903

NCT06727903 Predictive Model for Mortality in Older People With Critical Illness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06727903
Status Recruiting
Phase
Sponsor Consorci Sanitari de l'Alt Penedès i Garraf
Condition Critical Illness
Study Type OBSERVATIONAL
Enrollment 450 participants
Start Date 2025-03-20
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 75 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
laboratory biomarker analysis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 450 participants in total. It began in 2025-03-20 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The present study aims to develop a predictive model to identify elderly patients with the highest likelihood of mortality upon admission to an intensive care unit.

Eligibility Criteria

Inclusion Criteria: * Men and women aged 75 or older. * Admission to an ICU from the Emergency Department. * Availability of or possibility to contact a participant's informant. * Informed consent for participation in the study, either by the participant or a valid legal representative. Exclusion Criteria: Participants meeting any of the following exclusion criteria will not be included in the study: * Patients transferred to the Emergency Department from a hospital ward. * Patients who die within the first 24 hours of ICU admission. * Patients admitted to Step-Down Units. * Patients requiring ICU admission for any of the following reasons: Orotracheal intubation or advanced cardiopulmonary resuscitation performed prior to arrival at the Emergency Department. AV block awaiting pacemaker implantation. Activation of the STEMI or Stroke care pathway. Post-cardiac catheterization for acute coronary syndrome. * Participation in another clinical study involving an intervention, procedure, or visit schedule that is incompatible with the present study.

Contact & Investigator

Central Contact

César Gálvez, Ph.D.

✉ cgalvez@csapg.cat

📞 +34 9389600325

Frequently Asked Questions

Who can join the NCT06727903 clinical trial?

This trial is open to participants of all sexes, aged 75 Years or older, studying Critical Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06727903 currently recruiting?

Yes, NCT06727903 is actively recruiting participants. Contact the research team at cgalvez@csapg.cat for enrollment information.

Where is the NCT06727903 trial being conducted?

This trial is being conducted at Badalona, Spain, Sant Pere de Ribes, Spain, Barcelona, Spain, Barcelona, Spain and 11 additional locations.

Who is sponsoring the NCT06727903 clinical trial?

NCT06727903 is sponsored by Consorci Sanitari de l'Alt Penedès i Garraf. The trial plans to enroll 450 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology